S-3 S-3 EX-FILING FEES 0001177648 ENANTA PHARMACEUTICALS INC N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 Y N 0001177648 2026-02-10 2026-02-10 0001177648 1 2026-02-10 2026-02-10 0001177648 2 2026-02-10 2026-02-10 0001177648 3 2026-02-10 2026-02-10 0001177648 4 2026-02-10 2026-02-10 0001177648 5 2026-02-10 2026-02-10 0001177648 6 2026-02-10 2026-02-10 0001177648 1 2026-02-10 2026-02-10 0001177648 2 2026-02-10 2026-02-10 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

ENANTA PHARMACEUTICALS INC

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Equity Common Stock, par value $0.01 per share 457(o)
Equity Preferred Stock, par value $0.01 per share 457(o)
Debt Debt Securities 457(o)
Other Warrants 457(o)
Other Units 457(o)
Fees to be Paid 1 Unallocated (Universal) Shelf 457(o) $ 150,000,000.00 0.0001381 $ 20,715.00
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 150,000,000.00

$ 20,715.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 11,106.90

Net Fee Due:

$ 9,608.10

Offering Note

1

This registration statement covers such indeterminate amount or number of the securities of each identified class as the registrant may from time to time issue at indeterminate prices which shall have an aggregate initial offering price not to exceed $150,000,000.00, including securities issuable upon conversion, exercise, exchange, redemption, repurchase or settlement of other securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional securities issuable by reason of any stock split, stock dividend or similar transaction, including anti-dilution provisions. The proposed maximum offering price per unit for the primary offering will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. Each security offered as a unit will represent an interest in two or more other securities, which may or may not be separable from one another.

Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims 1 Enanta Pharmaceuticals, Inc. S-3 333-275723 11/22/2023 $ 11,106.90 Unallocated (Universal) Shelf Unallocated (Universal) Shelf $ 75,250,000.00
Fee Offset Sources Enanta Pharmaceuticals, Inc. S-3 333-275723 11/22/2023 $ 12,870.00

Rule 457(p) Statement of Withdrawal, Termination, or Completion:

1

On November 22, 2023, the registrant filed a Registration Statement on Form S-3 (File No. 333-275723), registering the offer and sale of up to $150,000,000.00 of securities (the "2023 Registration Statement"), of which $75,250,000.00 remain unsold (the "Unsold Securities"). The registrant paid a registration fee of $12,870.00 in connection with the 2023 Registration Statement (excluding $9,270 in fee offsets from a previously-filed prospectus supplement to a prospectus included in a Registration Statement on Form S-3). The 2023 Registration Statement and the offering of the Unsold Securities thereunder have been terminated. Pursuant to Rule 457(p) under the Securities Act, the registrant hereby applies $11,106.90 of the registration fee previously paid in connection with the 2023 Registration Statement in connection with the Unsold Securities to offset the current registration fee that is payable in connection with the registration of securities on this registration statement.

Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date

N/A N/A N/A N/A N/A N/A N/A N/A